Skip to main content
. 2021 Feb 10;89(4):769–779. doi: 10.1002/ana.26020

TABLE 1.

Clinical–Paraclinical Features at the Time of PML Diagnosis in the 9 Patients Treated with T Cell Therapy

Pt Age, yr/Sex Delay from Symptom Onset to PML Diagnosis (mo) Neurological Presentation Brain MRI Features JC Virus DNA in the CSF, Copies/ml
1 59/F 4 Right arm motor deficit Single lesion in frontal prerolandic region Negative a
2 55/M 4.8 Cognitive impairment, left arm segmental ataxia Multiple bilateral lesions in the frontal lobes, centrum semiovale, and in the posterior limb of the internal capsule 3,950
3 70/F 1.4 Aphasia, agraphia, alexia Single lesion involving the temporoparietal lobe 2,440
4 50/M 0.8 Left LHH Multiple lesions involving bilaterally the temporo‐occipital lobes and the corpus callosum 9,000
5 68/M 4 Cognitive impairment, left LHH Multiple lesions involving unilaterally the right parietal and occipital lobes 2,277
6 54/M 1 Left arm motor deficit Multiple lesions involving unilaterally the right frontal and parietal lobes 1,024
7 66/M 1 Left hemiparesis Multiple lesions located bilaterally in the frontal lobes 1,300
8 54/F 3.7 Left arm segmental ataxia, nausea, gait ataxia Multiple lesions located in the brainstem and the cerebellum 300
9 17/M 0.3 Cognitive impairment, left hemiparesis Multiple lesions in right parietal region, left temporoparietal regions, frontomesial region, corpus callosum, and basal ganglia 384
a

This patient had 109 copies of JC virus DNA/100,000 cells on brain biopsy tissue.

CSF = cerebrospinal fluid; F = female; LHH = lateral homonymous hemianopia; M = male; MRI = magnetic resonance imaging; PML = progressive multifocal leukoencephalopathy; Pt = patient.